Intensity Therapeutics (INTS) Earnings Date & Reports

Intensity Therapeutics Inc is a late-stage clinical biotechnology company passionately committed to applying scientific leadership in the field of localized cancer reduction to anti-cancer immune activation... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

INTS is expected to report earnings to fall 13.96% to -95 cents per share on November 17

Intensity Therapeutics INTS Stock Earnings Reports

Q3'26

Est.

$-0.95

Q2'26

Missed

by $0.24

Q1'26

Missed

by $0.90

Q4'25

Missed

by $1.26

Q3'25

Est.

$-0.06

The last earnings report on August 11 showed earnings per share of -111 cents, missing the estimate of -87 cents. With 11.32K shares outstanding, the current market capitalization sits at 15.87M.

View a ticker or compare two or three

INTS

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days